Home > Research > Publications & Outputs > Are Cannabis Use Problems Comparable Across Ind...

Electronic data

  • Sznitman et al DRUGPO-D-23-514_R2

    Accepted author manuscript, 1.77 MB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

View graph of relations

Are Cannabis Use Problems Comparable Across Individuals Using for Recreational and Medical Purposes?: An International Cross-Sectional Study of Individuals Who Use Self-Grown Cannabis

Research output: Contribution to Journal/MagazineJournal articlepeer-review

E-pub ahead of print
  • Sharon Sznitman
  • Gary Potter
  • Jodie Grigg
  • Ashely Granville
  • Pekka Hakkarainen
  • Tom Decorte
  • Simon Lenton
  • Davide Fortin
  • Daniel Bear
  • Irma Kirtadze
  • Marie Jauffret-Roustide
  • Monica Barratt
  • Eric Sevigny
Close
Article number104263
<mark>Journal publication date</mark>11/12/2023
<mark>Journal</mark>International Journal of Drug Policy
Publication StatusE-pub ahead of print
Early online date11/12/23
<mark>Original language</mark>English

Abstract

Background: Little is known about cannabis use problems among individuals who use cannabis for medical purposes and whether rates and determinants of cannabis use problems in medical users differ to those observed among individuals using for recreational reasons. This study examines whether Severity of Dependence Scale (SDS) scores differ across individuals who use self-grown cannabis for the following reasons: “recreational only”, “medical and recreational” and “medical only”.
Furthermore, the study tests whether cannabis use frequency, cannabis strain, and type of cannabis influences the strength of the association between purpose of use and cannabis use problems.
Methods: Data (n = 5,347) were collected from a subsample of the Global Cannabis Cultivation Research Consortium project, focusing on small-scale cannabis growers in 18 countries. Robust regressions analyzed differences in SDS scores across the three
use motivation groups.
Results: Compared with respondents reporting only recreational motivations of cannabis use, those with medical (with and without recreational) motivations were associated with lower SDS scores (B: -0.190 and B: -0.459, p < 0.001 respectively).
Daily use was associated with significantly higher SDS scores across all cannabis motivation groups, albeit the magnitude of the association was significantly smaller among individuals with medical motivations of use.
Conclusion: The extent to which people experience cannabis use problems, and the determinants of these problems may differ depending on whether cannabis use is motivated by recreational or medical purposes. As such, the findings of the current study suggest that public education efforts, harm reduction approaches and policy responses should be tailored depending on whether cannabis is used for recreational or medical purposes.